 Diagnosis monitoring inflammatory bowel diseases rely clinical, endoscopic, radiologic parameters. Inflammatory biomarkers investigated surrogate marker endoscopic diagnosis inflammatory activity. Fecal inflammatory biomarkers calprotectin lactoferrin direct products bowel inflammation provide accurate noninvasive diagnostic monitoring modality Crohn's disease ulcerative colitis. report contains overview currently existing literature pertaining clinical implications fecal biomarkers diagnosis, monitoring, prediction outcomes inflammatory bowel disease.